Middle East and Africa Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)     

Code: TIPRE00027458 | Pages: 127 | Industry: Medical Device | Date: Mar 2022 | Type: Regional

The MEA cervical cancer diagnostic testing market is expected to grow from US$ 218.90 million in 2021 to US$ 282.38 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2021 to 2028.

The cervical cancer diagnosis test market players focus on launching new products to expand their geographic reach and enhance capacities to cater to a greater than existing customer base. In November 2021, Hologic, Inc. launched the Genius Digital Diagnostics System for cervical cancer screening. Next-generation screening systems combine deep earning-based artificial intelligence (AI) with the latest volumetric imaging technology to assess precancerous lesions and cervical cancer cells in women. Similarly, in 2019, BD’s COR PX/GX system was launched, which is available in centralized labs across region since 2019 to assist in high-volume processing and increase overall efficiency. Similarly, one popular government insurance program provides cover for PAP tests, pelvic exams, and clinical breast examinations performed every two years for cervical cancer screening. Such programs and developments and launches of new products are likely to bring new trends in the MEA cervical cancer diagnosis test market in the coming years, thereby supporting its growth.

 

In case of COVID-19, MEA is highly affected especially South Africa. The healthcare sector in the UAE has undergone a considerable number of infrastructure and procedural changes to position itself as a leading healthcare provider. These improvements have been more recently recognized throughout the COVID-19 pandemic due to the continuous investments made to improve the sector’s hard and soft infrastructure. However, COVID-19 is likely to continue to have a notable impact on healthcare operations in countries. The pandemic had a major impact on a wide range of health outcomes. Disordering of elective health services related to cervical screening, management of abnormal screening test results, and treatment of pre-cancers, that lead to increase in cervical cancer incidence and inflame existing health disproportions. Since, the beginning of 2020, the pandemic has caused enormous health, social and economic impacts, likely to continue in 2021. Even after some of these impacts have been mitigated or contained, there will be medium and longer-term consequences. In many countries, diagnostics services have been disrupted, and supply chains for key commodities have been stretched. In Africa, COVID-19 has threatened the control of major health conditions including cervical cancer. As COVID-19 continues to spread in Africa, there are concerns over its impact on market, limited diagnosis, and decreased access to expert gynecologists further impacting the market in the region. However, as the pandemic situation overcomes, the demand for several diagnostics modalities used in cervical cancer diagnosis will increase. 

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA cervical cancer diagnostic testing market. The MEA cervical cancer diagnostic testing market is expected to grow at a good CAGR during the forecast period. 

 

MEA Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

MEA Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

Get more information on this report :

 

MEA Cervical Cancer Diagnostic Testing Market Segmentation 

MEA Cervical Cancer Diagnostic Testing Market – By Type

  • PAP Testing
  • HPV Testing
  • Colposcopy
  • Cervical Biopsies
  • Cystoscopy
  • Others

MEA Cervical Cancer Diagnostic Testing Market – By Service Provider

  • Diagnostics and Research Laboratories
  • Hospitals and Clinics
  • Specialty Clinics
  • Home Care Services

MEA Cervical Cancer Diagnostic Testing Market, by Country

  • South Africa
  • Saudi Arabia   
  • UAE 
  • Rest of MEA

MEA Cervical Cancer Diagnostic Testing Market - Companies Mentioned

  • Abbott
  • BD
  • Cooper Companies, Inc.
  • F. Hoffmann-La Roche Ltd.  
  • Femasys Inc.
  • Guided Therapeutics, Inc
  • Hologic, Inc.  
  • QIAGEN
  • Quest Diagnostics Incorporated   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Cervical Cancer Diagnostic Testing Market – By Type

1.3.2        MEA Cervical Cancer Diagnostic Testing Market – By Service Provider

1.3.3        MEA Cervical Cancer Diagnostic Testing Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Cervical Cancer Diagnostic Testing Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Cervical Cancer Diagnostic Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Prevalence of Cervical Cancer

5.1.2        Escalating HPV Infections

5.2         Market Restraints

5.2.1        Deficiency of Awareness about the Diagnosis and Treatment Methods

5.3         Market Opportunities

5.3.1        Development Opportunities in Emerging Countries

5.4         Future Trends

5.4.1        Rising Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Cervical Cancer Diagnostic Testing Market – MEA Analysis

6.1         MEA Cervical Cancer Diagnostic Testing Market Revenue Forecast and Analysis

7.           MEA Cervical Cancer Diagnostic Testing Market Analysis – By Type

7.1         Overview

7.2         MEA Cervical Cancer Diagnostic Testing Market, By Type, 2021 & 2028 (%)

7.3         PAP Testing

7.3.1        Overview

7.3.2        PAP Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         HPV Testing

7.4.1        Overview

7.4.2        HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Colposcopy

7.5.1        Overview

7.5.2        Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Cervical Biopsies

7.6.1        Overview

7.6.2        Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.7         Cystoscopy

7.7.1        Overview

7.7.2        Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

8.           MEA Cervical Cancer Diagnostic Testing Market Analysis – By Service Provider

8.1         Overview

8.2         MEA Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

8.3         Diagnostics and Research Laboratories

8.3.1        Overview

8.3.2        Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hospitals and Clinics

8.4.1        Overview

8.4.2        Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Specialty Clinics

8.5.1        Overview

8.5.2        Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Home Care services

8.6.1        Overview

8.6.2        Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Cervical Cancer Diagnostic Testing Market – Country Analysis

9.1         MEA: Cervical Cancer Diagnostic Testing Market

9.1.1        Overview

9.1.2        MEA: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)

9.1.2.1          Saudi Arabia: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1          Saudi Arabia: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2          Saudi Arabia Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.2.1.3          Saudi Arabia: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)

9.1.2.2          UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1          UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2          UAE Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.2.2.3          UAE: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)

9.1.2.3          South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1          South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2          South Africa Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.2.3.3          South Africa: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)

9.1.2.4          Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1          Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2          Rest of MEA Cervical Cancer Diagnostic Testing Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)

9.1.2.4.3          Rest of MEA: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on MEA Cervical Cancer Diagnostic Testing Market

10.1      MEA: Impact Assessment of COVID-19 Pandemic

11.        MEA Cervical Cancer Diagnostic Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      F. Hoffmann-La Roche Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Quest Diagnostics Incorporated

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      QIAGEN

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Femasys Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Guided Therapeutics, Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cooper Companies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      BD

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             MEA Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Veterinary Vaccines Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)

Table 4.             UAE Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 5.             UAE Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)

Table 6.             South Africa Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 7.             South Africa Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of MEA Cervical Cancer Diagnostic Testing Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of MEA Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)

Table 10.          Organic Developments

Table 11.          Inorganic Developments

Table 12.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           MEA Cervical Cancer Diagnostic Testing Market Segmentation

Figure 2.           MEA Cervical Cancer Diagnostic Testing Market, By Country

Figure 3.           MEA Cervical Cancer Diagnostic Testing Market Overview

Figure 4.           PAP Testing Segment Held Largest Share of the Market in 2021

Figure 5.           South Africa is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           MEA: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to MEA Cervical Cancer Diagnostic Testing Market

Figure 9.           MEA Cervical Cancer Diagnostic Testing Market Forecast to 2028

Figure 10.        MEA Cervical Cancer Diagnostic Testing Market, by Type, 2021 & 2028 (%)

Figure 11.        MEA Pap Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        MEA HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        MEA Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        MEA Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        MEA Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        MEA Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        MEA Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

Figure 18.        MEA Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        MEA Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        MEA Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        MEA Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        MEA: Cervical Cancer Diagnostic Testing Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        MEA: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)

Figure 24.        Saudi Arabia: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic on Cervical cancer diagnostics testing Market in MEA Countries

  1. Abbott
  2. BD
  3. Cooper Companies, Inc.
  4. F. Hoffmann-La Roche Ltd.
  5. Femasys Inc.
  6. Guided Therapeutics, Inc  
  7. Hologic, Inc.
  8. QIAGEN
  9. Quest Diagnostics Incorporated       
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000